Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the older notices, including the lapse in government funding message and Revision: v3.4.1.SummaryDifference0.4%

- Check20 days agoChange DetectedAdded a government funding lapse notice warning of possible delays in updating information and directing users to cc.nih.gov and opm.gov for status. Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedUI and metadata refinements were added (glossary toggle, updated last update labels, and version information), while the core study data and eligibility details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; there are no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section added listing Texas sites (Conroe, The Woodlands, Houston, and West Houston MD Anderson campuses); HHS Vulnerability Disclosure and Texas Locations were removed, and the revision updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedPublications section now notes that publications are automatically filled from PubMed. The page revision has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.